Habig Scott Michael has filed 4 insider transactions across 1 company since February 2024.
Most recent transaction: a sale of 18249 shares of Aurinia Pharmaceuticals Inc. ($AUPH) on August 06, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 6, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Habig Scott Michael | Chief Commercial Officer | S | Common Stock | 18249 | $5.31 | 456,338.0000 | 143,236,000 | 3.85% | 0.01% |
| March 6, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Habig Scott Michael | Chief Commercial Officer | S | Common Stock | 17777 | $5.60 | 474,587.0000 | 143,236,000 | 3.61% | 0.01% |
| Feb. 20, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Habig Scott Michael | Chief Commercial Officer | A | Common Stock | 195512 | $0.00 | 508,231.0000 | 143,236,000 | 62.52% | 0.14% |
| Feb. 20, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Habig Scott Michael | Chief Commercial Officer | S | Common Stock | 15867 | $5.48 | 492,364.0000 | 143,236,000 | 3.12% | 0.01% |